| Literature DB >> 35683853 |
Siyu Liu1, Tianlin Wang1, Shenglong Li1, Xiaohong Wang1,2.
Abstract
Additive manufacturing, also known as three-dimensional (3D) printing, relates to several rapid prototyping (RP) technologies, and has shown great potential in the manufacture of organoids and even complex bioartificial organs. A major challenge for 3D bioprinting complex org unit ans is the competitive requirements with respect to structural biomimeticability, material integrability, and functional manufacturability. Over the past several years, 3D bioprinting based on sacrificial templates has shown its unique advantages in building hierarchical vascular networks in complex organs. Sacrificial biomaterials as supporting structures have been used widely in the construction of tubular tissues. The advent of suspension printing has enabled the precise printing of some soft biomaterials (e.g., collagen and fibrinogen), which were previously considered unprintable singly with cells. In addition, the introduction of sacrificial biomaterials can improve the porosity of biomaterials, making the printed structures more favorable for cell proliferation, migration and connection. In this review, we mainly consider the latest developments and applications of 3D bioprinting based on the strategy of sacrificial biomaterials, discuss the basic principles of sacrificial templates, and look forward to the broad prospects of this approach for complex organ engineering or manufacturing.Entities:
Keywords: organ manufacturing; sacrificial biomaterials; three-dimensional (3D) bioprinting; vascularization
Year: 2022 PMID: 35683853 PMCID: PMC9182955 DOI: 10.3390/polym14112182
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.967
Figure 1Overview of the main application scenarios of sacrificial biomaterials based on physical and chemical polymer crosslinking principles in 3D bioprinting. Top: The use of a physical crosslinked sacrificial polymer to form a tubular vascular network. Bottom: The use of a chemical crosslinked sacrifice polymer as a support bath to print the required vascular network.
Advantages and disadvantages of several commonly used sacrificial biomaterials for organ manufacturing.
| Biomaterials | Principle | Bioprinting Method | Advantage | Deficiency | Application | References |
|---|---|---|---|---|---|---|
| PVA | Physical | Fused deposition modeling | Biocompat ibility; water soluble | High printing temperature; not bioactive | Microtubule network | [ |
| Pluronic F127 | Physical | Extrusion 3D printing | Bio-friendly; | Not bioactive | Microtubule network | [ |
| Gelatin | Physical | Extrusion 3D printing | bio-friendly; | Complex manufact uring process | Suspension medium/ | [ |
| Carbopol® | Physical | Extrusion 3D printing | bio-friendly; | - | Suspension medium | [ |
| Alginate | Chemical | Inkjet 3D printing/ | Bio-friendly; | Difficult to remove | Tubular tissue/supporting structure/ | [ |
| Modified hyalur- | Chemical | Extrusion 3D printing/stereo lithography 3D printing | Bio-friendly; | Difficult to synthesize; | Suspension medium | [ |
Figure 2(a) Chemical structure of Pluronic F127 and the principle of temperature sensitivity. (b,c) Pluronic F127 as a sacrificial biomaterial for printing microvascular networks (scale bar = 10 mm [88]. Reprinted with permission from Ref. [88]. Copyright 2011, copyright Wu et al. (d,e) Pluronic F127 as a sacrificial biomaterial for printing interconnected channels [74]. Reprinted with permission from Ref. [74]. Copyright 2014, copyright Kolesky et al. (f) Pluronic F127 as a sacrificial biomaterial for printing perfusable renal tubules [73]. Reprinted with permission from Ref. [73]. Copyright 2016, copyright Homan et al.
Figure 3Three-dimensional (3D) bioprinting of chondrocytes, cardiomyocytes, hepatocytes, and adipose-derived stem cells (ASCs) into living tissues/organs using a pioneered 3D bioprinter made at Tsinghua University in Prof. Wang’s laboratory: (a) the pioneered 3D bioprinter; (b) schematic description of a cell-laden gelatin-based hydrogel being printed into a grid lattice using the 3D bioprinter; (c) schematic description of the cell-laden gelatin-based hydrogel being printed into large scaled-up 3D construct using the 3D bioprinter; (d) 3D printing process of a chondrocyte-laden gelatin-based construct; (e) a grid 3D construct made from a cardiomyocyte-laden gelatin-based hydrogel; (f) hepatocytes encapsulated in a gelatin-based hydrogel after 3D printing; (g) hepatocytes in a gelatin-based hydrogel after 3D printing; (h) a gelatin-based hydrogel after 3D printing; (i–p) hepatocytes in some gelatin-based hydrogels after certain periods of in vitro cultures [99].
Figure 4A large scaled-up 3D printed bioartificial organ with vascularized liver tissue constructed through the double-nozzle 3D bioprinter created at Tsinghua Unversity in Prof. Wang’s laboratory: (a) the double-nozzle 3D bioprinter; (b) a computer-aided design (CAD) model containing a branched vascular network; (c) a CAD model containing the branched vascular network; (d) a few layers of the 3D bioprinted construct containing both adipose-derived stem cells (ASCs) encapsulated in a gelatin/alginate/fibrin hydrogel and hepatocytes encapsulated in a gelatin/alginate/chitosan hydrogel; (e–h) 3D printing process of a semi-elliptical construct containing both ASCs and hepatocytes encapsulated in different hydrogels; (i–l) hepatocytes encapsulated in the gelatin-based hydrogels after 3D bioprinting and different periods of in vitro cultures; (m–p) ASCs encapsulated in gelatin-based hydrogels after 3D bioprinting and different periods of in vitro culture as well as growth factor induction [99].
Figure 5(a) Gelatin particles prepared by mechanical force. (b) Gelatin microspheres prepared by coacervation method. (c) A schematic diagram of the arterial tree printed in a gelatin microgel supporting bath. (d) A cross section of the 3D printed heart in fluorescent alginate. (e) Dark field image of the 3D printed heart. (f) Side view of the brain printed with alginate. (g) The top view of the 3D printed brain. (h) MRI-derived 3D human heart scaled to neonatal size. (i) FRESH-printed collagen heart. (j,k) Top and side views of the FRESH-printed collagen heart valve with barium sulfate added for X-ray contrast. Scale bars: 10 mm in (c) and 1 cm in (d–g); (a,c,d,f,g) are from reference [45], Reprinted with permission from Ref. [45]. Copyright 2015, copyright Hinton et al. (b,h,i,j,k) are from reference [38], Reprinted with permission from Ref. [38]. Copyright 2019, copyright Lee et al.
Figure 6(a) Changing the rheology of the Carbopol bath by shielding the electrostatic repulsion between Carbopol ions to remove the Carbopol support bath. (b) After photo-crosslinking, the Carbopol support bath was removed by mechanical peeling [43], Reprinted with permission from Ref. [43]. Copyright 2020, copyright Zhao et al.
Figure 7(a) Schematic diagram of the application of alginate as a sacrificial biological material in 3D bioprinting. (b) 3D bioprinting a heart structure in a suspension bath composed of alginate [127], Reprinted with permission from Ref. [127]. Copyright 2019, copyright Noor et al.
Figure 8(a) 3D bioprinting a branched channel. After the 3D printed ‘bioink’ was UV crosslinked, a flow driven by pressure caused the supporting suspension to be removed, leaving the branched channel structure [120]. (b) 3D bioprinting a self-supporting structure. After the 3D printed ‘bioink’ was crosslinked by UV irradiation, the supporting suspension was dissolved by excess β-CD [120]. Scale bar 500 μm. Reprinted with permission from Ref. [120]. Copyright 2015, copyright Highley et al.
Figure 9A combined four-nozzle organ three-dimensional (3D) bioprinting technology created at Tsinghua Unversity in Prof. Wang’s laboratory in 2013 [99]: (a) equipment of the combined four-nozzle organ 3D bioprinter; (b) working state of the combined four-nozzle organ 3D printer; (c) a computer aided design (CAD) model representing a large scaled-up vascularized and innervated hepatic tissue; (d) a semi-ellipse 3D construct containing a poly (lactic acid-co-glycolic acid) (PLGA) overcoat, a hepatic tissue made from hepatocytes in a gelatin/chitosan hydrogel, a branched vascular network with fully confluent endothelialized adipose-derived stem cells (ASCs) on the inner surface of the gelatin/alginate/fibrin hydrogel and a hierarchical neural (or innervated) network made from Schwann cells in the gelatin/hyaluronate hydrogel, the maximal diameter of the semi-ellipse can be adjusted from 1 mm to 2 cm according to the CAD model; (e) a cross section of (d), showing the endothelialized ASCs and Schwann cells around a branched channel; (f) a large bundle of nerve fibers formed in (d); (g) hepatocytes underneath the PLGA overcoat; (h) an interface between the endothelialized ASCs and Schwann cells in (d); (i) some thin nerve fibers.